|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-2-11
|
|
pubmed:abstractText |
High-density lipoprotein (HDL) exerts a variety of anti-atherothrombotic functions, including a potent anti-inflammatory impact. In line, the direct pro-inflammatory effects of C-reactive protein (CRP) can be attenuated by HDL in vitro.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1538-7836
|
|
pubmed:author |
pubmed-author:BasserR LRL,
pubmed-author:BirjmohunR SRS,
pubmed-author:BisoendialR JRJ,
pubmed-author:FranssenRR,
pubmed-author:KasteleinJ JJJ,
pubmed-author:KuivenhovenJ AJA,
pubmed-author:LevelsJ H MJH,
pubmed-author:MeijersJ C MJC,
pubmed-author:StroesE SES,
pubmed-author:de KortHH,
pubmed-author:van LeuvenS ISI
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
347-54
|
|
pubmed:meshHeading |
pubmed-meshheading:18983488-Adult,
pubmed-meshheading:18983488-Apolipoprotein A-I,
pubmed-meshheading:18983488-Atherosclerosis,
pubmed-meshheading:18983488-C-Reactive Protein,
pubmed-meshheading:18983488-Endothelial Cells,
pubmed-meshheading:18983488-Humans,
pubmed-meshheading:18983488-Inflammation,
pubmed-meshheading:18983488-Male,
pubmed-meshheading:18983488-Middle Aged,
pubmed-meshheading:18983488-Phosphatidylcholines,
pubmed-meshheading:18983488-Recombinant Proteins,
pubmed-meshheading:18983488-Thrombosis
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans.
|
|
pubmed:affiliation |
Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. s.i.vanleuven@amc.uva.nl
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
